Table 1.
Cancer Type | Gene/Pathway | Prediction | Ref. |
---|---|---|---|
Colorectal cancer | CD133 | Poor response to fluorouracil-based chemotherapy | [44] |
Esophageal cancer | Hedgehog pathway | Poor response to chemo-radiotherapy | [50] |
Ewing sarcoma | Wnt pathway | VIDE regimen: tumor regression | [49] |
Glioblastoma | CD133 EGFR | Poor survival after radio-chemotherapy | [45] |
Head/neck cancer | BMI1 | Poor survival after radio-chemotherapy | [46] |
NSCLC | BMI1 | Poor disease-free survival after adjuvant chemotherapy | [47] |
NSCLC | CD133 | High expression of drug-resistance genes | [51] |
Rectal cancer | CD133 | Poor disease-free survival after neoadjuvant chemotherapy | [48] |